Evidence map›Paper›PMID 39138218›Full record

ArticleNature communications2024

TFEB activation hallmarks antigenic experience of B lymphocytes and directs germinal center fate decisions.

Matthias Münchhalfen, Richard Görg, Michael Haberl, Jens Löber, Jakob Willenbrink, Laura Schwarzt, Charlotte Höltermann, Christian Ickes, Leonard Hammermann, Jan Kus and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A guide to B cell metabolism.Nature reviews. Immunology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Matthias MünchhalfenInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0002-9240-9342
Richard GörgInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0003-4513-8698
Michael HaberlInstitute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.ORCID 0009-0002-3586-8435
Jens LöberDepartment of Medical Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.
Jakob WillenbrinkInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
Laura SchwarztInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
Charlotte HöltermannInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
Christian IckesInstitute of Cardiovascular Physiology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.ORCID 0009-0008-8717-1713
Leonard HammermannInstitute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.ORCID 0009-0009-7159-7581
Jan KusInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
Björn ChapuyDepartment of Medical Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.
Andrea BallabioTelethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.ORCID 0000-0003-1381-4604
Sybille D ReichardtInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0002-5316-2690
Alexander FlügelInstitute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
Niklas EngelsInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0003-2341-4954
Jürgen WienandsInstitute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany. jwienan@gwdg.de.ORCID 0000-0001-8278-7668

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1328, Project A01 - 335447717Deutsche Forschungsgemeinschaft (German Research Foundation) TRR 274/2 2024 - 408885537Deutsche Forschungsgemeinschaft (German Research Foundation) TRR 274, Project A08EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) Grant agreement No. 101021345 (T-Neuron)
6 · The paper itself

Abstract

Ligation of the B cell antigen receptor (BCR) initiates humoral immunity. However, BCR signaling without appropriate co-stimulation commits B cells to death rather than to differentiation into immune effector cells. How BCR activation depletes potentially autoreactive B cells while simultaneously primes for receiving rescue and differentiation signals from cognate T lymphocytes remains unknown. Here, we use a mass spectrometry-based proteomic approach to identify cytosolic/nuclear shuttling elements and uncover transcription factor EB (TFEB) as a central BCR-controlled rheostat that drives activation-induced apoptosis, and concurrently promotes the reception of co-stimulatory rescue signals by supporting B cell migration and antigen presentation. CD40 co-stimulation prevents TFEB-driven cell death, while enhancing and prolonging TFEB's nuclear residency, which hallmarks antigenic experience also of memory B cells. In mice, TFEB shapes the transcriptional landscape of germinal center B cells. Within the germinal center, TFEB facilitates the dark zone entry of light-zone-residing centrocytes through regulation of chemokine receptors and, by balancing the expression of Bcl-2/BH3-only family members, integrates antigen-induced apoptosis with T cell-provided CD40 survival signals. Thus, TFEB reprograms antigen-primed germinal center B cells for cell fate decisions.

Indexed as

ApoptosisBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsB-LymphocytesCD40 AntigensGerminal CenterReceptors, Antigen, B-CellAnimalsAntigen PresentationCell DifferentiationLymphocyte ActivationMiceMice, Inbred C57BLSignal TransductionBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCD40 AntigensReceptors, Antigen, B-CellTcfeb protein, mouse

Identifiers

PMID39138218
PMCPMC11322606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.